382 related articles for article (PubMed ID: 15087261)
1. Soy isoflavones in the treatment of prostate cancer.
Hussain M; Banerjee M; Sarkar FH; Djuric Z; Pollak MN; Doerge D; Fontana J; Chinni S; Davis J; Forman J; Wood DP; Kucuk O
Nutr Cancer; 2003; 47(2):111-7. PubMed ID: 15087261
[TBL] [Abstract][Full Text] [Related]
2. Lycopene and soy isoflavones in the treatment of prostate cancer.
Vaishampayan U; Hussain M; Banerjee M; Seren S; Sarkar FH; Fontana J; Forman JD; Cher ML; Powell I; Pontes JE; Kucuk O
Nutr Cancer; 2007; 59(1):1-7. PubMed ID: 17927495
[TBL] [Abstract][Full Text] [Related]
3. Effects of a genistein-rich extract on PSA levels in men with a history of prostate cancer.
deVere White RW; Hackman RM; Soares SE; Beckett LA; Li Y; Sun B
Urology; 2004 Feb; 63(2):259-63. PubMed ID: 14972467
[TBL] [Abstract][Full Text] [Related]
4. Clinical characteristics and pharmacokinetics of purified soy isoflavones: multiple-dose administration to men with prostate neoplasia.
Fischer L; Mahoney C; Jeffcoat AR; Koch MA; Thomas BE; Valentine JL; Stinchcombe T; Boan J; Crowell JA; Zeisel SH
Nutr Cancer; 2004; 48(2):160-70. PubMed ID: 15231450
[TBL] [Abstract][Full Text] [Related]
5. The specific role of isoflavones in reducing prostate cancer risk.
Kumar NB; Cantor A; Allen K; Riccardi D; Besterman-Dahan K; Seigne J; Helal M; Salup R; Pow-Sang J
Prostate; 2004 May; 59(2):141-7. PubMed ID: 15042614
[TBL] [Abstract][Full Text] [Related]
6. Serum prostate-specific antigen but not testosterone levels decrease in a randomized soy intervention among men.
Maskarinec G; Morimoto Y; Hebshi S; Sharma S; Franke AA; Stanczyk FZ
Eur J Clin Nutr; 2006 Dec; 60(12):1423-9. PubMed ID: 16775579
[TBL] [Abstract][Full Text] [Related]
7. Effects of a diet rich in phytoestrogens on prostate-specific antigen and sex hormones in men diagnosed with prostate cancer.
Dalais FS; Meliala A; Wattanapenpaiboon N; Frydenberg M; Suter DA; Thomson WK; Wahlqvist ML
Urology; 2004 Sep; 64(3):510-5. PubMed ID: 15351581
[TBL] [Abstract][Full Text] [Related]
8. Induction of apoptosis in low to moderate-grade human prostate carcinoma by red clover-derived dietary isoflavones.
Jarred RA; Keikha M; Dowling C; McPherson SJ; Clare AM; Husband AJ; Pedersen JS; Frydenberg M; Risbridger GP
Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1689-96. PubMed ID: 12496063
[TBL] [Abstract][Full Text] [Related]
9. Combined inhibitory effects of soy isoflavones and curcumin on the production of prostate-specific antigen.
Ide H; Tokiwa S; Sakamaki K; Nishio K; Isotani S; Muto S; Hama T; Masuda H; Horie S
Prostate; 2010 Jul; 70(10):1127-33. PubMed ID: 20503397
[TBL] [Abstract][Full Text] [Related]
10. Effects of a high dose, aglycone-rich soy extract on prostate-specific antigen and serum isoflavone concentrations in men with localized prostate cancer.
deVere White RW; Tsodikov A; Stapp EC; Soares SE; Fujii H; Hackman RM
Nutr Cancer; 2010; 62(8):1036-43. PubMed ID: 21058191
[TBL] [Abstract][Full Text] [Related]
11. Soy isoflavones do not modulate prostate-specific antigen concentrations in older men in a randomized controlled trial.
Adams KF; Chen C; Newton KM; Potter JD; Lampe JW
Cancer Epidemiol Biomarkers Prev; 2004 Apr; 13(4):644-8. PubMed ID: 15066931
[TBL] [Abstract][Full Text] [Related]
12. A pilot dose-escalation study of the effects of nordihydroguareacetic acid on hormone and prostate specific antigen levels in patients with relapsed prostate cancer.
Ryan CJ; Harzstark AH; Rosenberg J; Lin A; Claros C; Goldfine ID; Kerner JF; Small EJ; Youngren JF
BJU Int; 2008 Feb; 101(4):436-9. PubMed ID: 18234062
[TBL] [Abstract][Full Text] [Related]
13. IGF-II serum levels increase discrimination between benign prostatic hyperplasia and prostate cancer and improve the predictive value of PSA in clinical staging.
Trojan L; Bode C; Weiss C; Mayer D; Grobholz R; Alken P; Michel MS
Eur Urol; 2006 Feb; 49(2):286-92; discussion 292. PubMed ID: 16386354
[TBL] [Abstract][Full Text] [Related]
14. Soy isoflavone genistein in prevention and treatment of prostate cancer.
Perabo FG; Von Löw EC; Ellinger J; von Rücker A; Müller SC; Bastian PJ
Prostate Cancer Prostatic Dis; 2008; 11(1):6-12. PubMed ID: 17923857
[TBL] [Abstract][Full Text] [Related]
15. Dutasteride and bicalutamide in patients with hormone-refractory prostate cancer: the Therapy Assessed by Rising PSA (TARP) study rationale and design.
Sartor O; Gomella LG; Gagnier P; Melich K; Dann R
Can J Urol; 2009 Oct; 16(5):4806-12. PubMed ID: 19796455
[TBL] [Abstract][Full Text] [Related]
16. Soy consumption and phytoestrogens: effect on serum prostate specific antigen when blood lipids and oxidized low-density lipoprotein are reduced in hyperlipidemic men.
Jenkins DJ; Kendall CW; D'Costa MA; Jackson CJ; Vidgen E; Singer W; Silverman JA; Koumbridis G; Honey J; Rao AV; Fleshner N; Klotz L
J Urol; 2003 Feb; 169(2):507-11. PubMed ID: 12544298
[TBL] [Abstract][Full Text] [Related]
17. The importance of human glandular kallikrein and its correlation with different prostate specific antigen serum forms in the detection of prostate carcinoma.
Recker F; Kwiatkowski MK; Piironen T; Pettersson K; Lümmen G; Wernli M; Wiefelspütz J; Graber SF; Goepel M; Huber A; Tscholl R
Cancer; 1998 Dec; 83(12):2540-7. PubMed ID: 9874461
[TBL] [Abstract][Full Text] [Related]
18. A phase II trial of a soy beverage for subjects without clinical disease with rising prostate-specific antigen after radical radiation for prostate cancer.
Kwan W; Duncan G; Van Patten C; Liu M; Lim J
Nutr Cancer; 2010; 62(2):198-207. PubMed ID: 20099194
[TBL] [Abstract][Full Text] [Related]
19. Decreased growth of human prostate LNCaP tumors in SCID mice fed a low-fat, soy protein diet with isoflavones.
Aronson WJ; Tymchuk CN; Elashoff RM; McBride WH; McLean C; Wang H; Heber D
Nutr Cancer; 1999; 35(2):130-6. PubMed ID: 10693166
[TBL] [Abstract][Full Text] [Related]
20. Combination of low dose of genistein and daidzein has synergistic preventive effects on isogenic human prostate cancer cells when compared with individual soy isoflavone.
Dong X; Xu W; Sikes RA; Wu C
Food Chem; 2013 Dec; 141(3):1923-33. PubMed ID: 23870911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
